dc.contributor.author | Faivre-Finn, C. | |
dc.contributor.author | Ozguroglu, M. | |
dc.contributor.author | Villegas, A. | |
dc.contributor.author | Daniel, D. | |
dc.contributor.author | Murakami, S. | |
dc.contributor.author | Hui, R. | |
dc.contributor.author | Lee, K. | |
dc.contributor.author | Cho, B. C. | |
dc.contributor.author | Kubota, K. | |
dc.contributor.author | Poole, L. | |
dc.contributor.author | Wadsworth, C. | |
dc.contributor.author | Dennis, P. | |
dc.contributor.author | Antonia, S. | |
dc.contributor.author | Vansteenkiste, J. | |
dc.contributor.author | Naidoo, J. | |
dc.date.accessioned | 2021-03-06T08:37:45Z | |
dc.date.available | 2021-03-06T08:37:45Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Vansteenkiste J., Naidoo J., Faivre-Finn C., Ozguroglu M., Villegas A., Daniel D., Murakami S., Hui R., Lee K., Cho B. C. , et al., "PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT", JOURNAL OF THORACIC ONCOLOGY, cilt.13, 2018 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_e1dabede-d3dc-408f-ba4f-d9643f012740 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/148692 | |
dc.identifier.uri | https://doi.org/10.1016/j.jtho.2018.08.350 | |
dc.language.iso | eng | |
dc.subject | Göğüs Hastalıkları ve Allerji | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | SOLUNUM SİSTEMİ | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.title | PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF THORACIC ONCOLOGY | |
dc.contributor.department | KU Leuven , , | |
dc.identifier.volume | 13 | |
dc.identifier.issue | 10 | |
dc.contributor.firstauthorID | 257549 | |